Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Caracò, Corrado ^a   Mozzillo, Nicola ^a   Marone, Ugo ^a   Simeone, Ester ^a   Benedetto, Lucia ^a   Di Monta, Gianluca ^a   Di Cecilia, Maria L ^a   Botti, Gerardo ^a   Ascierto, Paolo A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cutaneous metastases; Electrochemotherapy; Melanoma

Indexed keywords

BLEOMYCIN;

ADULT; ADVERSE OUTCOME; ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; DRUG TOLERABILITY; ELECTROCHEMOTHERAPY; FEMALE; FOLLOW UP; HUMAN; IN-TRANSIT METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; MYALGIA; NECROSIS; OUTCOME ASSESSMENT; PAIN; SKIN METASTASIS; TREATMENT RESPONSE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; DISEASE-FREE SURVIVAL; ELECTROCHEMOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84888390679     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-564     Document Type: Article

References (19)

1. Leon P, Daly J, Synnestvedt M, Schultz DJ, Elder DE, Clark WH. The prognostic implications of microscopic satellites in patients with clinical Stage I melanoma. Arch Surg 1991, 126:1461-1468. 10.1001/archsurg.1991.01410360031006, 1842174.
2. Kretschmer L, Beckmann I, Thoms KM, Mitteldorf C, Bertsch HP, Neumann C. Factors predicting the risk of in-transit recurrence after sentinel lymphadenectomy in patients with cutaneous malignant melanoma. Ann Surg Oncol 2006, 13:1105-1112. 10.1245/ASO.2006.07.020, 16865591.
3. Marty M, Garbay JM, Gehl J, et al. Electrochemotherapy an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer 2006, 4:3-13.
4. Pawlik TM, Ross MI, Thompson JF, Eggermont AM, Gershenwald JE. The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. J Clin Oncol 2006, 23:4588-4590.
5. Mir LM. Based and rationale of the electrochemotherapy. Eur J Cancer 2006, 4(Suppl):38-44.
6. Larkin JO, Collins CG, Aarons S, et al. Electrochemotherapy: aspects of preclinical development and early clinical experience. Ann Surg 2007, 245:469-479. 10.1097/01.sla.0000250419.36053.33, 1877027, 17435555.
7. Gehl J. Electrochemotherapy : theory and methods, perspectives for drug delivery gene therapy and research. Acta Physiol Scand 2003, 177:437-447. 10.1046/j.1365-201X.2003.01093.x, 12648161.
8. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumors. Eur J Surg Oncol 2007, 34:232-240.
9. Gehl J, Geersen PF. Efficient palliation of haemorragic malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 2000, 10:585-589. 10.1097/00008390-200012000-00011, 11198481.
10. Quaglino P, Mortera C, Osella-Abate S, et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 2008, 15:2215-2222. 10.1245/s10434-008-9976-0, 18498012.
11. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: systemic antitumor effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res 2000, 10:381-385. 10.1097/00008390-200008000-00010, 10985673.
12. Kaehler KC, Egberts F, Hauschild A. Electrochemotherapy in symptomatic melanoma skin metastases: intraindividual comparison with conventional surgery. Dermatol Surg 2010, 36:1200-1202. 10.1111/j.1524-4725.2010.01608.x, 20533932.
13. Mozzillo N, Caracò C, Mori S, et al. Use of neoadjuvantelectrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanoma. J Transl Med 2012, 10:131. 10.1186/1479-5876-10-131, 3403981, 22800396.
14. Moller MG, Salwa S, Soden DM, et al. Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma. Expert Rev Anticancer Ther 2009, 9:1611-1630. 10.1586/era.09.129, 19895245.
15. Kis E, Olah J, Ocsai H, et al. Electrochemotherapy of cutaneous metastases of melanoma. A case series study and systematic reviewe of the evidence. Dermatol Surg 2011, 37:816-824. 10.1111/j.1524-4725.2011.01951.x, 21605245.
16. Colombo GL, Di Matteo S, Mir LM. Cost-effectiveness analyses of electrochemotherapy with the Cliniporatorvs other methods for the control and treatments of cutaneous and subcutaneous tumors. Therap Clin Risk Manag 2008, 4:1-8.
17. Campana LG, Mocellin S, Basso M, et al. Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol 2009, 16:191-199. 10.1245/s10434-008-0204-8, 18987914.
18. Sanki A, Kam PC, Thompson JF, et al. Long-term results of hyperthermic, isolated limbperfusion for melanoma: a reflection of tumor biology. Ann Surg 2007, 245:591-596. 10.1097/01.sla.0000251746.02764.fc, 1877051, 17414608.
19. Snoj M, Paulin-Kosir Z, Cemazar S, Sersa G. Long lasting complete response in melanoma treated by electrochemotherapy. Eur J Cancer 2006, 4(Suppl):2.